Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.14 - $19.14 $454,200 - $574,200
30,000 Added 100.0%
60,000 $923,000
Q2 2024

Aug 14, 2024

SELL
$14.62 - $18.42 $2.24 Million - $2.83 Million
-153,400 Reduced 83.64%
30,000 $487,000
Q1 2024

May 15, 2024

BUY
$17.79 - $30.86 $3.26 Million - $5.66 Million
183,400 New
183,400 $3.39 Million
Q3 2023

Nov 14, 2023

BUY
$20.84 - $33.47 $937,800 - $1.51 Million
45,000 Added 163.64%
72,500 $1.51 Million
Q2 2023

Aug 14, 2023

BUY
$17.8 - $25.65 $489,500 - $705,375
27,500 New
27,500 $658,000
Q3 2022

Nov 14, 2022

SELL
$14.11 - $18.27 $282,200 - $365,400
-20,000 Reduced 30.77%
45,000 $738,000
Q2 2022

Aug 15, 2022

SELL
$13.01 - $27.22 $243,287 - $509,014
-18,700 Reduced 22.34%
65,000 $916,000
Q1 2022

May 13, 2022

SELL
$20.94 - $27.5 $732,900 - $962,500
-35,000 Reduced 29.49%
83,700 $2.03 Million
Q4 2021

Feb 11, 2022

SELL
$16.79 - $27.09 $2.22 Million - $3.58 Million
-132,300 Reduced 52.71%
118,700 $2.77 Million
Q1 2021

May 17, 2021

BUY
$25.02 - $54.99 $4.15 Million - $9.12 Million
165,800 Added 194.6%
251,000 $6.47 Million
Q4 2020

Feb 16, 2021

BUY
$41.04 - $56.79 $1.23 Million - $1.7 Million
30,000 Added 54.35%
85,200 $4.56 Million
Q2 2020

Aug 14, 2020

BUY
$39.26 - $52.73 $2.17 Million - $2.91 Million
55,200 New
55,200 $2.68 Million
Q1 2020

May 15, 2020

SELL
$31.65 - $46.87 $2.53 Million - $3.75 Million
-80,000 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$36.21 - $51.4 $724,200 - $1.03 Million
20,000 Added 33.33%
80,000 $3.42 Million
Q3 2019

Nov 14, 2019

SELL
$22.22 - $44.01 $1.51 Million - $2.99 Million
-67,900 Reduced 53.09%
60,000 $2.16 Million
Q2 2019

Aug 13, 2019

BUY
$23.32 - $28.12 $2.17 Million - $2.61 Million
92,900 Added 265.43%
127,900 $3.42 Million
Q1 2019

May 14, 2019

BUY
$16.17 - $27.38 $565,950 - $958,300
35,000 New
35,000 $940,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.